| human | Q5 |
| P6178 | Dimensions author ID | 01011320522.06 |
| P496 | ORCID iD | 0000-0001-7232-1039 |
| P1153 | Scopus author ID | 35512895600 |
| P69 | educated at | Ohio State University | Q309331 |
| Wexner Medical Center at Ohio State University | Q7990266 | ||
| University of Colorado Health | Q30287856 | ||
| P108 | employer | Indiana University School of Medicine | Q2123017 |
| Richard L. Roudebush VA Medical Center | Q30253390 | ||
| Dayton VA Medical Center | Q30279800 | ||
| P734 | family name | Travers | Q19754983 |
| P735 | given name | Jeffrey | Q13028078 |
| Jeffrey | Q13028078 | ||
| P106 | occupation | researcher | Q1650915 |
| Q35604056 | Acquired STAT4 deficiency as a consequence of cancer chemotherapy |
| Q40682431 | Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. |
| Q40230119 | Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. |
| Q34288140 | Altered cytokine production by dendritic cells from infants with atopic dermatitis |
| Q36814937 | Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis. |
| Q77628540 | Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783 |
| Q40069379 | Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor |
| Q40652435 | Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor |
| Q40929966 | Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. |
| Q41627366 | Binding of carbamyl-platelet-activating factor to the Raji lymphoblast platelet-activating factor receptor |
| Q34613089 | Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor |
| Q41842617 | Chloroquine Promotes Apoptosis in Melanoma Cells by Inhibiting BH3 Domain–Mediated PUMA Degradation |
| Q36625266 | Cigarette Smoke Exposure Inhibits Contact Hypersensitivity via the Generation of Platelet-Activating Factor Agonists |
| Q77374028 | Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis |
| Q34494245 | Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions |
| Q42462788 | Development of trichodysplasia spinulosa: case report of a patient with Gorlin syndrome treated with vismodegib |
| Q79347646 | Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis |
| Q88959734 | Early assessment of burn severity in human tissue ex vivo with multi-wavelength spatial frequency domain imaging |
| Q33901930 | Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis |
| Q47139765 | Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse. |
| Q33872427 | Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production. |
| Q34720289 | Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. |
| Q40757922 | Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. |
| Q38889998 | Examining the differences in current regulatory processes for sunscreens and proposed safety assessment paradigm. |
| Q41024589 | Expression of the Platelet-activating Factor Receptor Results in Enhanced Ultraviolet B Radiation-induced Apoptosis in a Human Epidermal Cell Line |
| Q33954838 | Fibroblast Senescence and Squamous Cell Carcinoma: How Wounding Therapies Could Be Protective |
| Q34179222 | Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin |
| Q42284542 | From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease. |
| Q43900123 | Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease. |
| Q28585229 | Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo |
| Q34643090 | Hydrofluoric acid exposure: a case report and review on the clinical presentation and management. |
| Q28594862 | Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro |
| Q34156771 | Identification of platelet-activating factor acetylhydrolase II in human skin |
| Q41101686 | Identification of sn-2 acetyl glycerophosphocholines in human keratinocytes |
| Q34110713 | Identification of staphylococcal protein A in infected atopic dermatitis lesions. |
| Q37737382 | Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. |
| Q38937094 | Impact of Age and Insulin-Like Growth Factor-1 on DNA Damage Responses in UV-Irradiated Human Skin |
| Q35572295 | Important implications and new uses of ablative lasers in dermatology: fractional carbon dioxide laser prevention of skin cancer. |
| Q42832538 | Increased Th2 activity and diminished skin barrier function cooperate in allergic skin inflammation. |
| Q35645419 | Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells. |
| Q48012870 | Insulin-like Growth Factor 1 Receptor Signaling Is Required for Optimal ATR-CHK1 Kinase Signaling in Ultraviolet B (UVB)-irradiated Human Keratinocytes. |
| Q41113979 | Insulin-like growth factor-1 receptor regulates repair of ultraviolet B-induced DNA damage in human keratinocytes in vivo. |
| Q35795383 | Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis |
| Q73470190 | Lymphocyte activation in the pathogenesis of psoriasis |
| Q38408903 | Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation. |
| Q71669816 | Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis |
| Q68577562 | Metabolism of 13-hydroxy-9,11-octadecadienoic acid by MOLT-4 lymphocytes |
| Q72419883 | Metabolism of leukotriene B4 (LTB4) and 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) in human keratinocytes |
| Q45196049 | Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. |
| Q47685513 | Multilevel symmetric neuropathic pruritus (MSNP) presenting as recalcitrant "generalized" pruritus |
| Q90946071 | Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches |
| Q33824495 | Noninvasive mesoscopic imaging of actinic skin damage using spatial frequency domain imaging. |
| Q24318114 | OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome |
| Q35932617 | Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. |
| Q38707649 | PARP14 limits severity of allergic skin disease |
| Q88475000 | Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms |
| Q102072936 | Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells |
| Q34149803 | Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A Photosensitivity |
| Q35798982 | Platelet-activating factor does not mediate UVB-induced local immune suppression |
| Q69587180 | Platelet-activating factor stimulates phosphatidylinositol hydrolysis in the rat myometrium |
| Q37190440 | Radiation therapy generates platelet-activating factor agonists |
| Q35052087 | Reversing the aging stromal phenotype prevents carcinoma initiation |
| Q33773485 | STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis |
| Q91313742 | Single Ablative Fractional Resurfacing Laser Treatment For Forearm Actinic Keratoses: 6-Month Follow-Up Data From An Intrapatient Comparison Between Treated and Untreated Sites |
| Q24563693 | Skin resurfacing procedures: new and emerging options |
| Q91508858 | Spironolactone Depletes the XPB Protein and Inhibits DNA Damage Responses in UVB-Irradiated Human Skin |
| Q33877619 | Staphylococcus δ-toxin induces allergic skin disease by activating mast cells |
| Q35438088 | Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists. |
| Q33721751 | The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. |
| Q36118884 | The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. |
| Q40668724 | The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. |
| Q41744306 | The metabolism of platelet-activating factor in human T-lymphocytes. |
| Q95337465 | Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor |
| Q28544768 | Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin |
| Q42603825 | Topical application of a vitamin D analogue exacerbates atopic dermatitis and induces the atopic dermatitis-like phenotype in Stat6VT mice. |
| Q34716311 | Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands. |
| Q33914386 | Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis. |
| Q35846347 | Treatment Outcomes of Secondarily Impetiginized Pediatric Atopic Dermatitis Lesions and the Role of Oral Antibiotics |
| Q42469704 | Trichodysplasia spinulosa in gorlin syndrome treated with vismodegib-reply. |
| Q33664877 | UVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor Signaling |
| Q39047723 | UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects. |
| Q36536607 | UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. |
| Q40860456 | Use of enhanced green fluorescent protein to monitor retroviral-mediated gene therapy in human keratinocytes. |
| Q36178572 | Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. |
| Q86174810 | Worsening of bullous pemphigoid following bacillus Calmette-Guérin treatment for bladder cancer |
| Q90976363 | Wounding with a microneedling device corrects the inappropriate ultraviolet B radiation response in geriatric skin |
| Q39846321 | cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors. |
| Q37142159 | p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics |
| Q41141361 | β-Oxidation of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid by MOLT-4 Lymphocytes |
Search more.